The Diagnostic Value of Ischemia-modified Albumin in Prostate Cancer
Aim:The aim of this study was to investigate whether serum ischemia-modified albumin (IMA) levels have a diagnostic value in prostate cancer (Pca).Methods:Thirty primary Pca patients and 30 age-matched healthy male subjects were included in this prospective case-control study. The patients were sele...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayinevi
2020-01-01
|
| Series: | Haseki Tıp Bülteni |
| Subjects: | |
| Online Access: |
http://www.hasekidergisi.com/archives/archive-detail/article-preview/the-diagnostic-value-of-schemia-modified-albumin-i/35953
|
| _version_ | 1797909770970071040 |
|---|---|
| author | Rahmi Aslan Recep Eryılmaz Mehmet Sevim Murat Demir Kerem Taken |
| author_facet | Rahmi Aslan Recep Eryılmaz Mehmet Sevim Murat Demir Kerem Taken |
| author_sort | Rahmi Aslan |
| collection | DOAJ |
| description | Aim:The aim of this study was to investigate whether serum ischemia-modified albumin (IMA) levels have a diagnostic value in prostate cancer (Pca).Methods:Thirty primary Pca patients and 30 age-matched healthy male subjects were included in this prospective case-control study. The patients were selected from the urology clinic of a tertiary university hospital. Healthy men included in the control group were selected from hospital staff and patient relatives. Patients with severe chronic diseases and other malignancies were excluded. Serum IMA level was measured using the colorimetric method. The results were reported in absorbance unit (ABSU).Results:Serum IMA levels were significantly higher in the study group when compared to the control group (0.843±0.76 and 0.443±0.49 ABSU, respectively; p=0.002). The mean IMA value in patients with a Gleason score ≥7 (1.08±0.053 ABSU) was significantly higher than in patients with Gleason score ≤6 (IMA 0.418±0.64 ABSU). According to the receiving operating characteristic (ROC) analysis, when the cut-off value was ABSU=0.57, the sensitivity and specificity were 80% and 56.7%, respectively.Conclusion:Serum concentrations of IMA are significantly elevated especially in clinically significant Pca patients. Its high sensitivity (80%) in ROC analysis suggests that IMA can be used an ancillary biomarker in diagnosis. |
| first_indexed | 2024-04-10T11:13:51Z |
| format | Article |
| id | doaj.art-896d34e53ce44ca381455e8ab4d4d0f6 |
| institution | Directory Open Access Journal |
| issn | 1302-0072 2147-2688 |
| language | English |
| last_indexed | 2024-04-10T11:13:51Z |
| publishDate | 2020-01-01 |
| publisher | Galenos Yayinevi |
| record_format | Article |
| series | Haseki Tıp Bülteni |
| spelling | doaj.art-896d34e53ce44ca381455e8ab4d4d0f62023-02-15T16:18:57ZengGalenos YayineviHaseki Tıp Bülteni1302-00722147-26882020-01-01581424710.4274/haseki.galenos.2019.541613049054The Diagnostic Value of Ischemia-modified Albumin in Prostate CancerRahmi Aslan0Recep Eryılmaz1Mehmet Sevim2Murat Demir3Kerem Taken4 Yüzüncü Yıl University Faculty of Medicine, Department of Urology, Van, Turkey Yüzüncü Yıl University Faculty of Medicine, Department of Urology, Van, Turkey Yüzüncü Yıl University Faculty of Medicine, Department of Urology, Van, Turkey University of Health Sciences, Van Traning and Research Hospital, Clinic of Urology Van, Turkey Yüzüncü Yıl University Faculty of Medicine, Department of Urology, Van, Turkey Aim:The aim of this study was to investigate whether serum ischemia-modified albumin (IMA) levels have a diagnostic value in prostate cancer (Pca).Methods:Thirty primary Pca patients and 30 age-matched healthy male subjects were included in this prospective case-control study. The patients were selected from the urology clinic of a tertiary university hospital. Healthy men included in the control group were selected from hospital staff and patient relatives. Patients with severe chronic diseases and other malignancies were excluded. Serum IMA level was measured using the colorimetric method. The results were reported in absorbance unit (ABSU).Results:Serum IMA levels were significantly higher in the study group when compared to the control group (0.843±0.76 and 0.443±0.49 ABSU, respectively; p=0.002). The mean IMA value in patients with a Gleason score ≥7 (1.08±0.053 ABSU) was significantly higher than in patients with Gleason score ≤6 (IMA 0.418±0.64 ABSU). According to the receiving operating characteristic (ROC) analysis, when the cut-off value was ABSU=0.57, the sensitivity and specificity were 80% and 56.7%, respectively.Conclusion:Serum concentrations of IMA are significantly elevated especially in clinically significant Pca patients. Its high sensitivity (80%) in ROC analysis suggests that IMA can be used an ancillary biomarker in diagnosis. http://www.hasekidergisi.com/archives/archive-detail/article-preview/the-diagnostic-value-of-schemia-modified-albumin-i/35953 imaprostatic cancerdiagnosisbio-marker |
| spellingShingle | Rahmi Aslan Recep Eryılmaz Mehmet Sevim Murat Demir Kerem Taken The Diagnostic Value of Ischemia-modified Albumin in Prostate Cancer Haseki Tıp Bülteni ima prostatic cancer diagnosis bio-marker |
| title | The Diagnostic Value of Ischemia-modified Albumin in Prostate Cancer |
| title_full | The Diagnostic Value of Ischemia-modified Albumin in Prostate Cancer |
| title_fullStr | The Diagnostic Value of Ischemia-modified Albumin in Prostate Cancer |
| title_full_unstemmed | The Diagnostic Value of Ischemia-modified Albumin in Prostate Cancer |
| title_short | The Diagnostic Value of Ischemia-modified Albumin in Prostate Cancer |
| title_sort | diagnostic value of ischemia modified albumin in prostate cancer |
| topic | ima prostatic cancer diagnosis bio-marker |
| url |
http://www.hasekidergisi.com/archives/archive-detail/article-preview/the-diagnostic-value-of-schemia-modified-albumin-i/35953
|
| work_keys_str_mv | AT rahmiaslan thediagnosticvalueofischemiamodifiedalbumininprostatecancer AT receperyılmaz thediagnosticvalueofischemiamodifiedalbumininprostatecancer AT mehmetsevim thediagnosticvalueofischemiamodifiedalbumininprostatecancer AT muratdemir thediagnosticvalueofischemiamodifiedalbumininprostatecancer AT keremtaken thediagnosticvalueofischemiamodifiedalbumininprostatecancer AT rahmiaslan diagnosticvalueofischemiamodifiedalbumininprostatecancer AT receperyılmaz diagnosticvalueofischemiamodifiedalbumininprostatecancer AT mehmetsevim diagnosticvalueofischemiamodifiedalbumininprostatecancer AT muratdemir diagnosticvalueofischemiamodifiedalbumininprostatecancer AT keremtaken diagnosticvalueofischemiamodifiedalbumininprostatecancer |